• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Hygienic Packaging Technology

    Trends in Solid Oral Dosage Delivery

    5 Reasons Paper Has No Place in Contract Manufacturing

    Injectable Drug Delivery Trends

    Pharmaceutical Manufacturing Equipment Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Innoforce and dMed Enter Development Collaboration

    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

    Four Female Leaders Appointed to Cell & Gene CDMO

    Fusion Pharmaceuticals Acquires IPN-1087

    Strata Oncology Unveils Strata PATH Trial
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

    WuXi AppTec Completes OXGENE Acquisition

    Trends in Solid Oral Dosage Delivery

    Injectable Drug Delivery Trends

    Oral Solids: Market & Technology Trends
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Hygienic Packaging Technology

    Reshaping the Pharmaceutical Supply Chain

    Serialization: Level 5 Solution

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Innoforce and dMed Enter Development Collaboration

    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

    Four Female Leaders Appointed to Cell & Gene CDMO

    Strata Oncology Unveils Strata PATH Trial

    Alimentiv Acquires McDougall Scientific
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    PCI Pharma Services

    Emergent BioSolutions

    Syngene

    Alcami
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Emergent BioSolutions

    PCI Pharma Services

    Aphena Pharma Solutions

    Alcami

    Baxter BioPharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    MedPharm Expands U.S. Footprint

    UK topical and transdermal firm invests in $4 million expansion of laboratory facility in Durham, NC.

    MedPharm Expands U.S. Footprint
    Tim Wright, Editor, Contract Pharma07.23.20
    MedPharm, a UK-based developer of topical and transdermal products, recently unveiled a substantial expansion at its Center of Excellence in Durham, NC. Supporting clients from discovery lead optimization to GMP clinical batch supply, MedPharm has facilities in Guildford, UK, in addition to the Durham site. The company’s expertise covers products to be applied to and/or through the skin, nail, eye, airway or mucosal membranes. Contract Pharma spoke with Jeremy Drummond, senior vice president of business development, about the expansion and MedPharm’s plans for future growth on both sides of the Atlantic.
     
    Contract Pharma (CP): Could you please tell me about the features of the Durham facility?
     
    Jeremy Drummond (JD): MedPharm’s facility in Durham, NC has recently been expanded to 25,000 square feet, tripling the area of the existing footprint. The $4 million investment will predominantly provide additional laboratory space and equipment.
     

    Medpharm's Jeremy Drummond
    In addition to the performance testing using our proprietary in vitro models based on human tissue, MedPharm now can offer pre-formulation/formulation development, histology and microbiology services out of North Carolina. Importantly the facility will also encompass a dedicated innovation laboratory to help solve unique problems presented by clients and ensure that MedPharm stays at the forefront of technology.
     
    This new facility will be able to accommodate 100 new highly skilled scientific personnel.
     
    CP: Why was the expansion necessary—were you looking to add capabilities in certain areas, capacity or both?
     
    JD: The expansion has become necessary because of the increased demand for MedPharm’s services across all sectors of the pharmaceutical industry. There is increased demand, from biotech start-ups to Big Pharma, to develop topical and transdermal products based on new chemical entities. These companies recognize the inherent risks in topical formulation development and increasingly appreciate how MedPharm’s specialist skills coupled with its in-depth experience can de-risk their development plans and help them to attract investors when they seek funding.
     
    The increased demand is fueled by the growing interest in developing new and repurposed drugs currently registered for oral or IV delivery for indications which require delivery through the skin, direct to the eye or into an airway. Another contributing factor has been MedPharm’s pioneering expertise in the use of in vitro models based on human tissue to meet the recently published FDA and EMEA guidances on demonstrating generic equivalence for topical medicines.
     
    MedPharm is now also attracting projects from OTC companies who are keen to use its in vitro models to help educate their key opinion leaders about their products and broaden the marketing claims of their products with regulatory authorities.
     
    This investment is just a first step in MedPharm’s vision to expand its services in the future, particularly around contract manufacturing.
     
    CP: Could you tell me a little more about the dedicated innovation laboratory—its features and capabilities?
     
    JD: MedPharm’s Innovation Laboratory has a wide-ranging remit to help customers resolve key questions to de-risk or simplify their product development.
     
    By example, recently the team has developed a new model for assessing penetration through human nasal epithelia based on air liquid interface tissue culture of primary human cells in the laboratory. This allows clients to assess the performance of their products before they commit to clinical trial decisions.
     
    In a further step, MedPharm has expanded these models based to support pharmaceutical development programs targeting Coronavirus treatments. These models allow clients to assess therapeutic effectiveness in nasal, airway (bronchial), and deep lung (alveolar) epithelia against members of the Coronaviridae family. The work will help to de-risk development programs and screen drugs for therapeutic effectiveness to accelerate development prior to clinical trials.
     
    Studies have shown that human tissue can vary significantly from that of animals used in in vivo models and so this approach provides the most realistic read out of how a topical drug product is going to behave in the clinical environment.
     
    In a similar way the innovation laboratory has refined MedPharm’s whole eye model for monitoring penetration to encompass the activity of formulations on key biochemical pathways and is extending the viability of fresh skin kept in the laboratory from weeks to months to open the opportunity for novel assays for monitoring wound healing and acne amongst others.


     
    Related Searches
    • Drug Delivery

    Related Online Exclusives

    • Drug Delivery
      Aerosol Delivery Devices Market

      Aerosol Delivery Devices Market

      Advantages over conventional drug delivery devices, rise in prevalence of COPD and asthma drive the growth of the global aerosol delivery devices market.
      Allied Market Research 02.16.21

    • Drug Delivery | Drug Development
      Inhaled Drug Delivery Technology Trends

      Inhaled Drug Delivery Technology Trends

      The success of new inhaled medicines relies on the correct combination of formulation and device technology.
      Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 11.24.20

    • Drug Delivery
      Topical Drugs Poised for Growth

      Topical Drugs Poised for Growth

      The topical drug delivery market is projected to reach $129.8 billion by 2025 from $95.2 billion in 2020, at a CAGR of 6.4%.
      Contract Pharma Staff 10.12.20


    • Drug Delivery
      Drug Delivery Market Report

      Drug Delivery Market Report

      The pharmaceutical drug delivery market was valued at $1,403,082.9 million in 2019 and is projected to reach $2,296,170.9 million by 2027.
      Contract Pharma Staff 10.12.20

    • Biologics, Proteins, Vaccines | Drug Delivery | Injectables
      Growth in Biologics and Maintaining Patient Satisfaction

      Growth in Biologics and Maintaining Patient Satisfaction

      Vicki A. Barbur of Battelle discusses the driving forces for biologics, the challenges, and new delivery methods
      Kristin Brooks, Contrct Pharma 08.09.19

    • Cold Chain Management | Drug Delivery | Industry News | Logistics
      The Logistics Behind Personalized Medicine Delivery

      The Logistics Behind Personalized Medicine Delivery

      Cryoport's chief commercial officer Mark W. Sawicki comments on the importance of their logistic solution services
      02.21.18


    • Drug Delivery
      Inventing the MDI: A History in Modern Inhalation Therapy

      Inventing the MDI: A History in Modern Inhalation Therapy

      3M’s Charlie Thiel offers insight into the pressurized metered-dose inhaler
      Lynn Melling, Contributing Author 04.19.17

    • Clinical Trials | Drug Delivery | Drug Development | Drug Discovery

      Overcoming Discovery Obstacles for Immunotherapies

      New immunology applications aim to further enhance discovery efforts
      Kristin Brooks 11.12.14

    • Aseptic Processing | Biologics, Proteins, Vaccines | Biosimilars | Capsules | Drug Delivery | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Inspections | Lyophilization | Methods Development | Parenterals | Process Development | QA/QC | R&D | Regulatory Affairs | Serialization | Solid Dosage/Semi-solids | Supply Chain | Validation | Vials
      West Pharmaceutical Services Q&A

      West Pharmaceutical Services Q&A

      We talk with West CEO Don Morel about the company's 90th anniversary
      Gil Roth 07.11.13


    • Bioassay Development | Capsules | Collaborations & Alliances | Drug Delivery | Drug Development | Excipients | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Lyophilization | Methods Development | Parenterals | Process Development | R&D | Scale-up/Technology Transfer | Solid Dosage/Semi-solids | Toxicology | Vials
      Halo/Altus Q&A

      Halo/Altus Q&A

      Halo's CEO discusses his recent formulation partnership
      Gil Roth 06.12.13

    Trending
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • AbbVie Opts To Acquire Mitokinin
    • Bormioli Opens New Glass Research Center
    • WuXi AppTec Completes OXGENE Acquisition
    • Arcline Investment Acquires ChargePoint Technology
    Breaking News
    • Innoforce and dMed Enter Development Collaboration
    • Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site
    • Four Female Leaders Appointed to Cell & Gene CDMO
    • Fusion Pharmaceuticals Acquires IPN-1087
    • Strata Oncology Unveils Strata PATH Trial
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Hygienic Packaging Technology
    • Trends in Solid Oral Dosage Delivery
    • 5 Reasons Paper Has No Place in Contract Manufacturing
    • Injectable Drug Delivery Trends
    • Pharmaceutical Manufacturing Equipment Trends
    • Oral Solids: Market & Technology Trends
    • Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow
    • 2021 Contract Manufacturing Survey
    • Small Molecule Development Trends
    • Challenges & Opportunities Facing Small & Emerging Biopharma Companies
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Maypro Launches Brain Heatlh Ingredient NeuroHD
    Gadot Biochemical Launches New Magnesium Ingredients
    Low Levels of Vitamin D and Calcium Linked to COVID-19 Severity
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies Adds Benjamin Woeste as Territory Sales Manager
    Matt Fogel Named Mule-Hide's Territory Manager – Southern Virginia
    Benjamin Moore Launches COMMAND
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Philips, Disney Join Forces to Reduce Childrens' MRI Anxiety
    Philips, Disney Partner to Improve MRI Experience for Children
    FDA OKs Asensus' Senhance for General Surgery
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Innoforce and dMed Enter Development Collaboration
    Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site
    Four Female Leaders Appointed to Cell & Gene CDMO
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    P&G Makes Progress Toward Packaging Circularity in Europe
    Coty Partners with LanzaTech to Introduce Sustainable Ethanol
    Remembering Fred Segal, a Trendsetting Retail Pioneer
    Happi

    Latest Breaking News From Happi

    Coty Partners with LanzaTech to Reduce Its Environmental Impact
    Waterless Beauty, Simplified Routines Shape Clean Beauty at Whole Foods
    Redken Updates Packaging, Adds New Products
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Ashland announces PSA price hike in North America
    Arrow Systems and Sihl form flexible packaging partnership
    Flint Group Packaging announces global price increase
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Joa Announces Expandable Absorbent Core Wrap Solution
    Principle Business Enterprises Celebrates 60 Years
    Mann+Hummel Invests in Pamlico Air
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Spinal Elements Relaunches the Luna XD and Orbit Systems
    Coronavirus Triggers Double-Digit Revenue Dropoff at Smith+Nephew
    FDA Approves Accufix Surgical's Accu-Joint Hemi Implant
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login